PDF Cover

Gamma Knife Radiosurgery Market

The market for Gamma Knife Radiosurgery was estimated at $812 million in 2024; it is anticipated to increase to $1.25 billion by 2030, with projections indicating growth to around $1.78 billion by 2035.

Report ID:DS1801249
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Medical Device
Gamma Knife Radiosurgery
Share
Report Summary
Market Data
Methodology
Table of Contents

Global Gamma Knife Radiosurgery Market Outlook

Revenue, 2024

$812M

Forecast, 2034

$1.66B

CAGR, 2025 - 2034

7.4%

The Gamma Knife Radiosurgery industry revenue is expected to be around $872.4 million in 2025 and expected to showcase growth with 7.4% CAGR between 2025 and 2034. Gamma Knife Radiosurgery holds promise in the field of healthcare due to recent technological advancements that allow for less invasive procedures for patients requiring neurosurgery. This innovative approach is gaining attention within the industry as more people become aware of and embrace these cutting edge surgical techniques. The growing prevalence of conditions globally further contributes to the demand, for Gamma Knife Radiosurgery services. The increasing number of individuals prone to brain related illnesses highlights its importance as well as the growing emphasis, on tailored medical treatments and personalized healthcare has significantly boosted its usage in current therapeutic practices.

Gamma Knife Radiosurgery is well known for its accuracy and effectiveness in targeting brain disorders using a system for stereotactic radiosurgery procedures. It is primarily used for treating malignant tumors as well, as vascular malformations and functional disorders in a non invasive manner.

Gamma Knife Radiosurgery market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2024-2034
Gamma Knife Radiosurgery Market Outlook

Market Key Insights

  • The Gamma Knife Radiosurgery market is projected to grow from $812.3 million in 2024 to $1.66 billion in 2034. This represents a CAGR of 7.4%, reflecting rising demand across Brain Metastasis Treatment, Treatment of Arteriovenous Malformations (AVM), and Trigeminal Neuralgia Management.

  • Elekta AB, Varian Medical Systems Inc, and Brainlab AG are among the leading players in this market, shaping its competitive landscape.

  • U.S. and Japan are the top markets within the Gamma Knife Radiosurgery market and are expected to observe the growth CAGR of 4.8% to 7.1% between 2024 and 2030.

  • Emerging markets including Brazil, India and South Africa are expected to observe highest growth with CAGR ranging between 8.5% to 10.2%.

  • Transition like Advancements in Radiosurgical Technology is expected to add $117 million to the Gamma Knife Radiosurgery market growth by 2030.

  • The Gamma Knife Radiosurgery market is set to add $846 million between 2024 and 2034, with manufacturer targeting Specialized Clinics & Cancer Research Institutes Application projected to gain a larger market share.

  • With

    rise in brain tumor cases, and

    Advancements in Technology, Gamma Knife Radiosurgery market to expand 104% between 2024 and 2034.

gamma knife radiosurgery market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Gamma Knife Radiosurgery - Country Share Analysis

Opportunities in the Gamma Knife Radiosurgery

In the field of Gamma Knife Radiosurgery d significant progress has also been made due to partnerships formed among hospitals and research institutions along with manufacturers sharing resources and knowledge which accelerates the advancement and acceptance of new technologies, in Gamma Knife Radiosurgery.

Growth Opportunities in North America and Asia Pacific

In North America. Mainly driven by the United States and Canada. There is a market share due to the aging population and strong healthcare system with a high incidence of brain tumors present in the region. Notably in this region of Gamma Knife Radiosurgery competition is fierce with investments being made in research and development to enhance current technology and better patient results. Key factors influencing the market are advancements in technology leading to healthcare spending along with growing awareness, among patients and healthcare professionals.
In the Asia Pacific regions perspective shift to the topic of Gamma Knife Radiosurgery market growth is considerable in countries such as India, China and Japan due to a growing class and improved healthcare facilities leading to an increase in neurological disorders prevalence. Both established and new players contribute to a competitive market landscape, in this region. In this region well progress in technology increased healthcare spending and growing knowledge of Gamma Knife Radiosurgery are driving market expansion. Players in this region have an edge due to their blend of top notch products with advanced technology and cost effectiveness, from scalable production methods.

Market Dynamics and Supply Chain

01

Driver: Rise in Brain Tumor Cases, and Shifting Preference Towards Non-Invasive Procedures

The rising occurrence of brain tumors globally plays a role in the market for Gamma Knife Radiosurgery treatment option which offers a less invasive and accurate approach to address differents of brain tumors compared to conventional surgical methods used in the past years The favorable results and minimal post surgical issues associated with Gamma Knife Radiosurgery make it an attractive choice, for both patients and healthcare providers alike. The medical field is also seeing a rise in the popularity of invasive or non invasive treatments lately—a trend that is also clearly reflected in the Gamma Knife Radiosurgery market’s dynamics. Gamma Knife Radiosurgery stands out for being non invasive and offering patients discomfort and quicker recovery times compared to traditional treatments—attributes that contribute to its growing favor, among patients seeking treatment options.
The ongoing advancements in technology within the sector. Especially in cancer treatment. Play a significant role in driving growth forward. a By incorporating imaging technologies and specialized planning software for surgeries a the accuracy of Gamma Knife Radiosurgery has also been greatly improved. a This improvement boosts the efficiency and accessibility of this technique an increasing its popularity and demand, in the market.
02

Restraint: High Treatment Costs

A major obstacle faced by the market for Gamma Knife Radiosurgery is the expense linked to this treatment method which is renowned for its advanced and efficient approach to addressing brain conditions; often resulting in a substantial financial burden for hospitals and medical establishments due to the high costs involved in procuring and upkeeping the equipment – expenses that are frequently passed down to patients and thereby restricting access to treatment, for a wide demographic of individuals. This poses an obstacle to the expansion of the market as it restricts the potential use of Gamma Knife Radiosurgery despite an increasing demand, for such treatments.
03

Opportunity: Expanding market in developing countries and Emerging applications of the technology

Numerous emerging nations are witnessing an uptick in tourism as a result of cost efficiency and improvements in healthcare facilities specifically countries like India and Thailand that present promising prospects for the expansion of the Gamma Knife Radiosurgery sector due to its recognized effectiveness in treating brain tumors and minimally invasive approach making it a favored choice among patients thereby highlighting profitable prospects for the market, in these areas.
The latest developments in Gamma Knife Radiosurgery give healthcare professionals accuracy and options for managing challenging medical issues effectively. There is growing evidence backing its use for treating conditions outside brain diseases like neck and spine tumors. This extension into treatment areas indicates a potential market opportunity and represents a substantial advancement, in the field.
04

Challenge: Limited Awareness and Skilled Professionals

Although Gamma Knife Radiosurgery represents a progress in neurosurgery practices; the lack of awareness about these treatment facilities and the scarcity of skilled professionals to carry out such procedures are affecting the industry's growth adversely. There is a possibility that patients might not only have knowledge about Gamma Knife as a viable treatment alternative; especially, in underdeveloped regions where healthcare education may be lacking.

Supply Chain Landscape

1

Raw Material Procurement

H C StarckATI Metals
2

Equipment Manufacturing

ElektaVarian Medical Systems
3

Distribution & Sales

Alpha Omega Services IncMUDr. Doleal
4

End-Users

Hospitals and ClinicsSpecialist Neurosurgery Centers
Gamma Knife Radiosurgery - Supply Chain

Use Cases of Gamma Knife Radiosurgery in Brain Metastasis Treatment & Trigeminal Neuralgia Management

Brain Metastasis Treatment : Gamma Knife Radiosurgery is often used as an approach to address metastatic brain tumors that typically occur when cancer spreads from another region of the body to the brain. Through the application of precise radiation by devices, like the Gamma Knife Perfexion, a focused effort is made to break down tumor cells while safeguarding nearby healthy tissues. This method proves beneficial in cases involving multiple tumors or those situated in challenging locations. Leading companies like Eleka AB and Varian Medical Systems are, at the forefront of offering this groundbreaking solution to meet the needs of a growing number of cancer patients.
Treatment of Arteriovenous Malformations (AVM) : Gamma Knife Radiosurgery is commonly used for treating malformations particularly with the Gamma Knife Icon technology option employed in such cases AVMs pose a serious threat as they involve an abnormal connection of arteries and veins that disrupts the natural flow of blood and oxygen within the body This cutting edge radiosurgery technique offers a minimally invasive yet highly successful treatment approach compared to traditional surgical interventions This has led to its popularity among healthcare professionals Key industry players like Elekta AB have designed specialized tools for AVM therapy which further solidify their dominant position, in the market.
Trigeminal Neuralgia Management : Gamma Knife radiosurgery is widely used to treat trigeminal neuralgia by delivering highly focused cobalt-60 beams to a precise neural target, typically guided through rigid stereotactic head-frame systems that ensure submillimetre accuracy. In comparison, some centers also use advanced frameless robotic steering systems that adjust beam direction in real time for added flexibility. Leading players include Elekta, known for its Leksell Gamma Knife precision platform, and Accuray, recognized for its robotic versatility in complex cranial treatments.Is

Recent Developments

Recent developments in Gamma Knife radiosurgery reflect a strategic push toward greater precision, workflow efficiency, and expanded clinical usability. Manufacturers are integrating advanced imaging, real-time treatment planning, and adaptive dose-control systems to improve outcomes for conditions such as brain tumors, AVMs, and functional neurological disorders. A notable market trend is the growing adoption of non-invasive stereotactic radiosurgery supported by shorter treatment times and improved patient comfort. As healthcare providers emphasize accuracy and reduced downtime, technologies leveraging focused radiation therapy, robotic positioning, and AI-enhanced planning are strengthening the competitive landscape and improving the scalability of Gamma Knife systems across global neuro-oncology centers.


December 2024 : ElektA B., a known company in the industry of medical technology has revealed new developments, in Gamma Knife Radiosurgery technology that now includes AI interfaces to enhance patient diagnostics and care.
October 2024 : Varian Medical Systems Inc has started a collaborative clinical research project to validate the advantages of Gamma Knife Radiosurgery in treating numerous metastases.
July 2024 : Accuray Incorporated teamed up with healthcare facilities to extend the reach of Gamma Knife Radiosurgery treatments to communities that have limited access, to healthcare services.

Impact of Industry Transitions on the Gamma Knife Radiosurgery Market

As a core segment of the Medical Device industry, the Gamma Knife Radiosurgery market develops in line with broader industry shifts. Over recent years, transitions such as Advancements in Radiosurgical Technology and Increasing Adoption due to NonInvasive Nature have redefined priorities across the Medical Device sector, influencing how the Gamma Knife Radiosurgery market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Advancements in Radiosurgical Technology

Throughout its history Gamma Knife Radiosurgery has seen technological advancements that have transformed the way various neurological diseases are treated. The increased precision and quicker treatment times have led to patient satisfaction and fewer side effects. Moreover the progress, in imaging technologies has enhanced the effectiveness of Gamma Knife Radiosurgery allowing healthcare professionals to provide more efficient treatment options.
02

Increasing Adoption due to NonInvasive Nature

The increasing popularity of invasive techniques has had a significant impact on the field of Gamma Knife Radiosurgery. The shift is fueled by the growing need for efficient treatment solutions. The evidence can be seen in the invasive nature of the procedure that notably shortens hospital stays and promotes faster healing processes. As a result of these benefits the utilization of Gamma Knife Radiosurgery has seen a rise in various healthcare facilities painting a promising outlook, for theindustry'sadvancement.